A Phase II Study Of PS-341 In Metastatic Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Bortezomib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 15 Jan 2013 Primary endpoints added as reported by ClinicalTrials.gov.
- 15 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 22 Aug 2006 Status change